文献速递创伤骨科骨质疏松与代谢性骨病

骨折患者COVID-19感染的临床特征与早期预后

Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

该研究汇总了湖北省8家医院2020年1月1日至2月27日收治的10例骨折合并COVID-19患者的临床特征与早期预后。所有患者均有骨折相关活动受限,常见表现为发热、咳嗽和乏力(各7例),6例淋巴细胞减少,9例D-二聚体和C反应蛋白升高,3例接受手术,4例死亡。骨折患者COVID-19的临床特征和早期预后较无骨折的成人COVID-19患者更严重,手术治疗应谨慎或选择非手术治疗。

要点

  • 骨折合并COVID-19患者常见发热、咳嗽、乏力,淋巴细胞减少及D-二聚体、CRP升高多见。
  • 10例中4例死亡,早期预后较无骨折成人COVID-19患者更差。
  • 疫情期间骨折患者尤其是老年转子间骨折者应谨慎手术或选择非手术治疗。

核心结论

  • 骨折患者COVID-19的临床特征和早期预后较无骨折的成人COVID-19患者更严重。
  • 这一差异可能与症状出现至就诊的时间间隔有关。
  • 在COVID-19疫区,骨折患者应谨慎手术或选择非手术治疗,尤其是老年转子间骨折患者。

研究设计与样本

  • 回顾性收集湖北省8家医院2020年1月1日至2月27日收治的10例骨折合并COVID-19患者数据。
  • 早期预后分析基于临床结局和治療期间实验室结果趋势。
  • 证据等级为预后Level IV。

主要发现

  • 所有10例患者均因骨折导致活动受限。
  • 最常见体征为发热、咳嗽和乏力,各7例。
  • 其他表现包括咽痛4例、呼吸困难5例、胸痛1例、鼻塞1例、头痛1例、头晕3例、腹痛1例、呕吐1例。
  • 淋巴细胞减少(<1.0×10^9/L)见于6/10例,D-二聚体升高见于9/9例,C反应蛋白升高见于9/9例。
  • 3例接受手术,其余因状态不佳接受非手术治疗;4例死亡(3例于入院后第8天,1例于第14天)。

关键数值与推荐

  • 淋巴细胞减少定义为<1.0×10^9/L,10例中6例符合。
  • D-二聚体升高9/9例,C反应蛋白升高9/9例。
  • 死亡4例中3例发生于入院后第8天,1例发生于第14天。

临床怎么用

  • 对骨折合并COVID-19患者应警惕发热、咳嗽、乏力及淋巴细胞减少等表现。
  • 在COVID-19疫区,骨折患者的手术治疗应谨慎进行,或选择非手术治疗。
  • 老年转子间骨折患者尤需慎重决策手术与非手术治疗。

局限性

  • 样本量仅10例,来自8家医院,结论外推受限。
  • 存活患者的临床结局尚未确定。
  • 证据等级为预后Level IV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies of the novel coronavirus-induced disease COVID-19 in Wuhan, China, have elucidated the epidemiological and clinical characteristics of this disease in the general population. The present investigation summarizes the clinical characteristics and early prognosis of COVID-19 infection in a cohort of patients with fractures. METHODS: Data on 10 patients with a fracture and COVID-19 were collected from 8 different hospitals located in the Hubei province from January 1, 2020, to February 27, 2020. Analyses of early prognosis were based on clinical outcomes and trends in laboratory results during treatment. RESULTS: All 10 patients presented with limited activity related to the fracture. The most common signs were fever, cough, and fatigue at the time of presentation (7 patients each). Other, less common signs included sore throat (4 patients), dyspnea (5 patients), chest pain (1 patient), nasal congestion (1 patient), headache (1 patient), dizziness (3 patients), abdominal pain (1 patient), and vomiting (1 patient). Lymphopenia (<1.0 × 10 cells/L) was identified in 6 of 10 patients, 9 of 9 patients had a high serum level of D-dimer, and 9 of 9 patients had a high level of C-reactive protein. Three patients underwent surgery, whereas the others were managed nonoperatively because of their compromised status. Four patients died on day 8 (3 patients) or day 14 (1 patient) after admission. The clinical outcomes for the surviving patients are not yet determined. CONCLUSIONS: The clinical characteristics and early prognosis of COVID-19 in patients with fracture tended to be more severe than those reported for adult patients with COVID-19 without fracture. This finding may be related to the duration between the development of symptoms and presentation. Surgical treatment should be carried out cautiously or nonoperative care should be chosen for patients with fracture in COVID-19-affected areas, especially older individuals with intertrochanteric fractures. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Mi B, Chen L, Xiong Y, et al. Characteristics and Early Prognosis of COVID-19 Infection in Fracture Patients. J Bone Joint Surg Am. 2020. PMID: 32379114. doi:10.2106/JBJS.20.00390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。